Free Trial
NASDAQ:ITOC

Itonic Q4 2025 Earnings Results & Report

$3.80 -0.14 (-3.55%)
Closing price 10/14/2026 04:00 PM Eastern
Extended Trading
$3.78 -0.01 (-0.39%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Itonic reported Q4 2025 earnings on March 30, 2026. The company reported EPS of -$1.4560, while revenue was $0.23 million.

Earnings Announcement Details

Quarter
Q4 2025
Report Date
Time
Before Market Opens

Itonic EPS Results

Actual EPS
-$1.4560
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Itonic Revenue Results

Actual Revenue
$0.23 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Itonic Q4 2025 Earnings FAQ

Itonic (NASDAQ:ITOC) reported earnings of -$1.4560 per share for Q4 2025. The report was announced on Monday, March 30, 2026.

Itonic reported revenue of $0.23 million for Q4 2025.

Itonic Earnings Headlines

Pheton (NASDAQ:PTHL) Stock Price Up 1.3% - What's Next?
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel
See More Itonic Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Itonic? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Itonic and other key companies, straight to your email.

About Itonic

Itonic (NASDAQ:ITOC), a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.

View Itonic Profile